From: Short and long-term outcomes of surgical intervention for empyema in the post-fibrinolytic era
Cohort Demographics, N = 18 | |
---|---|
Patient age at procedure (years), M ± SD Patient age range | 59.44 ± 14.67 31–79 |
Gender, n (%) | |
Male | 11 (61.1) |
Female | 7 (38.9) |
Ethnicity/Race, n (%) | |
Non-Hispanic, Caucasian | 9 (50.0) |
Black, African American | 4 (22.2) |
Asian | 1 (5.6) |
Hispanic | 1 (5.6) |
Other, Unknown | 3 (16.6) |
Smoking History, n (%) | |
Yes | 9 (50.0) |
No | 9 (50.0) |
Comorbidities, n | |
Cancer, metastatic | 7 |
Cancer, local | 2 |
COPD or Reactive airway disease | 4 |
HTN/CAD | 7 |
Organ transplant | 1 |
HIV/AIDs | 1 |
CVA/stroke | 2 |
Cerebral Palsy | 1 |
None | 2 |
Charlson Comorbidity Index Score | Predicted 10-year survival |
0 (n = 3) | 98% |
1 (n = 1) | 96% |
3 (n = 2) | 77% |
5 (n = 3) | 21% |
6 (n = 4) | 2% |
8 (n = 1) | 0% |
9 (n = 3) | 0% |
12 (n = 1) | 0% |
Indication for OWT, n (%) | |
Post-resectional BPF | 9 (50.0) |
Post-pneumonectomy | 5 |
Post-lobectomy | 4 |
Parapneumonic Empyema | 5 (27.8) |
Esophageal Related | 1 (5.6) |
Subdiaphragmatic Abscess | 1 (5.6) |
Post-traumatic BPF | 2 (11.1) |